Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NOK 3.2
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Arctic Bioscience AS, a biotechnology company, develops and commercializes pharmaceutical and nutraceutical products. Its development stage product candidate is HRO350, a novel oral treatment for mild-to-moderate psoriasis. The company sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta,...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Data is available to registered users only
